Last reviewed · How we verify
NCT03772756
EUS-RFA for Unresectable Pancreatic Ductal Adenocarcinoma
NA trial testing Endoscopic ultrasound guided radiofrequency ablation in Pancreatic Adenocarcinoma Non-resectable in 38 participants. Completed in 16 August 2021.
16 August 2021
Quick facts
| Lead sponsor | First People's Hospital of Hangzhou |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 38 |
| Start date | 20 December 2018 |
| Primary completion | 16 August 2021 |
| Estimated completion | 16 August 2021 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Endoscopic ultrasound guided radiofrequency ablation
- chemoradiotherapy — full drug profile →
Conditions studied
- Pancreatic Adenocarcinoma Non-resectable — all drugs for Pancreatic Adenocarcinoma Non-resectable →
Sponsor
First People's Hospital of Hangzhou
Who can join
Adults 20 to 80, any sex, with Pancreatic Adenocarcinoma Non-resectable. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the study evaluate the efficacy and safety of EUS-RFA using Habib EUS-RFA catheter with a prospective randomised trial in patients with inoperable PDAC.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Harnessing endoscopic ultrasound-guided radiofrequency ablation to reshape the pancreatic ductal adenocarcinoma microenvironment and elicit systemic immunomodulation.
Moond V, Maniyar B, Harne PS, Bailey-Lundberg JM, et al · · 2024 · cited 6× · PMID 39351436 · DOI 10.37349/etat.2024.00263
Verify or expand the search:
- PubMed search for NCT03772756
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Endoscopic ultrasound guided radiofrequency ablation
Trials testing the same drug.
- NCT05453292 — Endoscopic Ultrasound Radiofrequency Ablation for GISTs · NA · unknown
- NCT03405025 — Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas · NA · completed
Other recruiting trials for Pancreatic Adenocarcinoma Non-resectable
Currently open trials in the same condition.
- NCT07481383 — A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly o · Phase 1 · recruiting
- NCT06090916 — Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic C · NA · active not recruiting
- NCT05524090 — PREOPANC-4 Implementation Program for Locally Advanced Pancreatic Cancer · recruiting
Other First People's Hospital of Hangzhou trials
Trials by the same sponsor.
- NCT07507825 — Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG) · Phase 2 · not yet recruiting
- NCT07390981 — Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder · NA · not yet recruiting
- NCT07242443 — Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Py · Phase 4 · not yet recruiting
- NCT07207278 — Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma · recruiting
- NCT06933992 — Safety and Efficacy of Chocolate Balloon Catheter in Peripheral Arterial Disease (CHOCO-PAD) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03772756 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by First People's Hospital of Hangzhou
- Last refreshed: 30 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03772756.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing